Welcome to LookChem.com Sign In|Join Free
  • or
(3S)-3-amino-N-benzyl-2-hydroxypentanamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

440125-15-5

Post Buying Request

440125-15-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

440125-15-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 440125-15-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,0,1,2 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 440125-15:
(8*4)+(7*4)+(6*0)+(5*1)+(4*2)+(3*5)+(2*1)+(1*5)=95
95 % 10 = 5
So 440125-15-5 is a valid CAS Registry Number.

440125-15-5Downstream Products

440125-15-5Relevant academic research and scientific papers

Norstatines from Aldehydes by sequential organocatalytic α-amination and passerini reaction

Umbreen, Sumaira,Brockhaus, Manfred,Ehrenberg, Helmut,Schmidt, Boris

, p. 4585 - 4595 (2007/10/03)

The combination of the enantioselective, organocatalytic α-amination of aldehydes by diazodicarboxylates and the Passerini reaction provides rapid access to norstatine-based peptidomimetics. These intermediates were elaborated further by deprotection and cleavage of the N-N bond to provide useful building blocks for aspartic protease inhibitors. Coupling of the compounds 76-86 with the mono-isophthalamide 91 provided moderate inhibitors of human β-secretase (BACE) 92-102. Wiley-VCH Verlag GmbH & Co. KGaA, 2006.

AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 46-47, (2010/02/09)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceu

PEPTIDIC COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page 69, (2010/11/30)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 440125-15-5